Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 2.3.2015 | EN | Official Journal of the European Union | C 73/12 |

---

Request for a preliminary ruling from the Cour d’appel de Paris (France) lodged on 9 December 2014 — Genentech Inc. v Hoechst GmbH, formerly Hoechst AG, Sanofi-Aventis Deutschland GmbH

(Case C-567/14)

(2015/C 073/18)

Language of the case: French

Referring court

Cour d’appel de Paris

Parties to the main proceedings

Applicant: Genentech Inc.

Defendant: Hoechst GmbH, formerly Hoechst AG, Sanofi-Aventis Deutschland GmbH

Question referred

‘Must the provisions of Article 81 of the Treaty (now Article 101 TFEU) be interpreted as precluding effect being given, where patents are revoked, to a licence agreement which requires the licencee to pay royalties for the sole use of the rights attached to the licensed patent?’

---

[Top](#document1)